U.S. markets closed

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
37.59+0.26 (+0.70%)
At close: 5:36PM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close37.33
Open37.35
Bid37.54 x N/A
Ask37.56 x N/A
Day's Range37.32 - 37.97
52 Week Range24.25 - 51.54
Volume1,196,753
Avg. Volume1,871,075
Market Cap24.699B
Beta (5Y Monthly)1.20
PE Ratio (TTM)11.56
EPS (TTM)3.25
Earnings DateFeb 23, 2021
Forward Dividend & Yield0.84 (2.25%)
Ex-Dividend DateAug 31, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      Switzerland's Vifor strikes kidney drug deal with Angion

      Swiss drugmaker Vifor Pharma on Monday agreed to pay United States-based Angion Biomedica up to $80 million for rights to experimental kidney drug ANG-3777. Angion's ANG-3777 is in late-stage trials to determine whether it helps kidney transplant patients at risk of impaired functioning of the donated organ. It is also in an earlier-stage study for acute kidney injury associated with cardiac surgery.

    • Is FRESENIUS SECO (FSNUY) a Great Value Stock Right Now?
      Zacks

      Is FRESENIUS SECO (FSNUY) a Great Value Stock Right Now?

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    • Should Value Investors Buy Fresenius (FMS) Stock?
      Zacks

      Should Value Investors Buy Fresenius (FMS) Stock?

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.